Cargando…
Impact of Chronic Kidney Disease on Use of Evidence-Based Therapy in Stable Coronary Artery Disease: A Prospective Analysis of 22,272 Patients
PURPOSE: To assess the frequency of chronic kidney disease (CKD), define the associated demographics, and evaluate its association with use of evidence-based drug therapy in a contemporary global study of patients with stable coronary artery disease. METHODS: 22,272 patients from the ProspeCtive obs...
Autores principales: | Kalra, Paul R., García-Moll, Xavier, Zamorano, José, Kalra, Philip A., Fox, Kim M., Ford, Ian, Ferrari, Roberto, Tardif, Jean-Claude, Tendera, Michal, Greenlaw, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106833/ https://www.ncbi.nlm.nih.gov/pubmed/25051258 http://dx.doi.org/10.1371/journal.pone.0102335 |
Ejemplares similares
-
Chronic Kidney Disease Has a Graded Association with Death and Cardiovascular Outcomes in Stable Coronary Artery Disease: An Analysis of 21,911 Patients from the CLARIFY Registry
por: Vidal-Petiot, Emmanuelle, et al.
Publicado: (2019) -
Heart Rate and Use of Beta-Blockers in Stable Outpatients with Coronary Artery Disease
por: Steg, Ph. Gabriel, et al.
Publicado: (2012) -
Rationale, design, and baseline characteristics of the CLARIFY registry of outpatients with stable coronary artery disease
por: Sorbets, Emmanuel, et al.
Publicado: (2017) -
Use of Anticoagulants and Antiplatelet Agents in Stable Outpatients with Coronary Artery Disease and Atrial Fibrillation. International CLARIFY Registry
por: Fauchier, Laurent, et al.
Publicado: (2015) -
Simple risk models to predict cardiovascular death in patients with stable coronary artery disease
por: Ford, Ian, et al.
Publicado: (2020)